Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
South Korea · Delayed Price · Currency is KRW 5,670.00
-150.00 (-2.58%)
At close: Jun 19, 2026
Daehan Nupharm Market Cap
Daehan Nupharm has a market cap or net worth of 79.58 billion as of June 18, 2026. Its market cap has decreased by -19.23% in one year.
Market Cap
79.58B
Enterprise Value
153.75B
Revenue
205.39B
Ranking
n/a
PE Ratio
5.08
Stock Price
5,670.00
Market Cap Chart
Since March 3, 2003, Daehan Nupharm's market cap has increased from 13.03B to 79.58B, an increase of 510.65%. That is a compound annual growth rate of 8.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 79.58B | -13.70% |
| Dec 30, 2025 | 92.21B | -4.37% |
| Dec 30, 2024 | 96.42B | -24.09% |
| Dec 28, 2023 | 127.02B | 5.97% |
| Dec 29, 2022 | 119.86B | -21.65% |
| Dec 30, 2021 | 152.98B | -13.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 91.63B |
| KOREA PHARMA | 91.40B |
| Samik Pharmaceutical Company LTD. | 84.16B |
| Sam-A Pharm. | 81.36B |
| Pharos iBio | 81.04B |
| Organoidsciences | 71.72B |
| GL Pharm Tech | 69.72B |
| Sinsin Pharmaceutical | 68.42B |